Working... Menu

Iron Absorption in Haiti

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02096250
Recruitment Status : Completed
First Posted : March 26, 2014
Last Update Posted : September 23, 2015
International Atomic Energy Agency
Information provided by (Responsible Party):
Isabelle Aeberli, Swiss Federal Institute of Technology

Brief Summary:
The government of Haiti plans to introduce a flour fortification program. The aim of the project it to inform the authorities on the most suitable iron compound for this fortification program. For this purpose, iron absorption from wheat flour using different iron compounds will be investigated.

Condition or disease Intervention/treatment Phase
Iron Deficiency Other: NaFeEDTA Other: Ferrous fumarate Other: NaFeEDTA + ferrous fumarate Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 44 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Basic Science
Official Title: Iron Absorption From Wheat Flour in Haiti
Study Start Date : June 2014
Actual Primary Completion Date : August 2014
Actual Study Completion Date : July 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Iron

Arm Intervention/treatment
Experimental: NaFeEDTA
Other: NaFeEDTA
Experimental: Ferrous fumarate
Ferrous fumarate
Other: Ferrous fumarate
Experimental: NaFeEDTA + ferrous fumarate
NaFeEDTA + ferrous fumarate
Other: NaFeEDTA + ferrous fumarate

Primary Outcome Measures :
  1. Iron absorption [ Time Frame: 14 days after test meal consumption ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Mother-child pairs will be recruited!

Inclusion criteria for mothers :

  • Women of reproductive age (18 to 45 years)
  • Generally healthy
  • Consenting to study participation

Exclusion criteria for mothers :

  • Pregnancy or lactation
  • Weight >65 kg
  • Chronic illnesses which may influence iron absorption
  • Severe anemia (Hb<10 g/dl)

Inclusion criteria for children:

  • Age 4 years +/- 12 months
  • Generally healthy

Exclusion criteria for children :

  • Severe anemia (Hb<10 g/dl)
  • Weight for height < -2 Z scores (wasting)
  • Height of age < -2 Z score (stunting)

Furthermore, the following exclusion criteria apply to both mothers and children :

  • Chronic illnesses or medication which may influence iron absorption (will be judged by investigator)
  • Consumption of vitamin or mineral supplement (unless they agree to discontinue using them two weeks before beginning of the study until the las visit)
  • Allergies or intolerances relevant to the test meal (gluten)
  • Blood donation or major blood losses during the 2 months prior to the study
  • Illness during the 4 weeks prior to the study (will be judged by investigator)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02096250

Layout table for location information
Ministère de la Santé Publique et de la Population
Port au Prince, Haiti
Sponsors and Collaborators
Swiss Federal Institute of Technology
International Atomic Energy Agency
Layout table for investigator information
Principal Investigator: Isabelle Aeberli, PhD ETH Zurich (Switzerland)

Layout table for additonal information
Responsible Party: Isabelle Aeberli, PhD, Swiss Federal Institute of Technology Identifier: NCT02096250     History of Changes
Other Study ID Numbers: EK 2013-N43
First Posted: March 26, 2014    Key Record Dates
Last Update Posted: September 23, 2015
Last Verified: September 2015

Additional relevant MeSH terms:
Layout table for MeSH terms
Anemia, Iron-Deficiency
Anemia, Hypochromic
Hematologic Diseases
Iron Metabolism Disorders
Metabolic Diseases
Ferrous fumarate
Edetic Acid
Ferric Compounds
Trace Elements
Growth Substances
Physiological Effects of Drugs
Iron Chelating Agents
Chelating Agents
Sequestering Agents
Molecular Mechanisms of Pharmacological Action
Calcium Chelating Agents